An Updated View of Translocator Protein (TSPO)
AbstractDecades of study on the role of mitochondria in living cells have evidenced the importance of the 18 kDa mitochondrial translocator protein (TSPO), first discovered in the 1977 as an alternative binding site for the benzodiazepine diazepam in the kidneys. This protein participates in a variety of cellular functions, including cholesterol transport, steroid hormone synthesis, mitochondrial respiration, permeability transition pore opening, apoptosis, and cell proliferation. Thus, TSPO has become an extremely attractive subcellular target for the early detection of disease states that involve the overexpression of this protein and the selective mitochondrial drug delivery. This special issue was programmed with the aim of summarizing the latest findings about the role of TSPO in eukaryotic cells and as a potential subcellular target of diagnostics or therapeutics. A total of 9 papers have been accepted for publication in this issue, in particular, 2 reviews and 7 primary data manuscripts, overall describing the main advances in this field. View Full-Text
Share & Cite This Article
Denora, N.; Natile, G. An Updated View of Translocator Protein (TSPO). Int. J. Mol. Sci. 2017, 18, 2640.
Denora N, Natile G. An Updated View of Translocator Protein (TSPO). International Journal of Molecular Sciences. 2017; 18(12):2640.Chicago/Turabian Style
Denora, Nunzio; Natile, Giovanni. 2017. "An Updated View of Translocator Protein (TSPO)." Int. J. Mol. Sci. 18, no. 12: 2640.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.